HDAC inhibitors in kidney development and disease

The discovery that histone deacetylase inhibitors (HDACis) can attenuate acute kidney injury (AKI)-mediated damage and reduce fibrosis in kidney disease models has opened the possibility of utilizing HDACis as therapeutics for renal injury. Studies to date have made it abundantly clear that HDACi tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Brilli, Lauren L., Swanhart, Lisa M., de Caestecker, Mark P., Hukriede, Neil A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751322/
https://www.ncbi.nlm.nih.gov/pubmed/23052657
http://dx.doi.org/10.1007/s00467-012-2320-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751322/
https://www.ncbi.nlm.nih.gov/pubmed/23052657
http://dx.doi.org/10.1007/s00467-012-2320-8

Ejemplares similares